Amgen Inc.
AMGN
$269.12
-$2.19-0.81%
| Weiss Ratings | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | B | |||
| Rating Factors | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Good | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.51 | |||
| Price History | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.19% | |||
| 30-Day Total Return | 2.91% | |||
| 60-Day Total Return | 3.25% | |||
| 90-Day Total Return | 16.92% | |||
| Year to Date Total Return | 2.95% | |||
| 1-Year Total Return | -3.54% | |||
| 2-Year Total Return | 28.39% | |||
| 3-Year Total Return | 18.80% | |||
| 5-Year Total Return | 45.04% | |||
| 52-Week High % Change | -6.70% | |||
| 52-Week Low % Change | 27.12% | |||
| Price | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $288.46 | |||
| 52-Week Low Price | $211.71 | |||
| 52-Week Low Price (Date) | Jun 01, 2023 | |||
| 52-Week High Price (Date) | Oct 13, 2023 | |||
| Valuation | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | $144.03B | |||
| Enterprise Value | 169.75B | |||
| Price/Earnings (TTM) | 19.14 | |||
| Earnings Per Share (TTM) | 14.06 | |||
| Earnings Per Share Growth | 12.78% | |||
| Price/Earnings To Growth | 1.50 | |||
| Price/Sales (TTM) | 5.40 | |||
| Price/Book (Q) | 18.81 | |||
| Enterprise Value/Revenue (TTM) | 6.33 | |||
| Price | $269.12 | |||
| Enterprise Value/EBITDA (TTM) | 12.78 | |||
| Enterprise Value/EBIT | 17.53 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 538.000M | |||
| Dividend Yield | 3.17% | |||
| Div. Per Share (Most Recent) | $2.13 | |||
| Dividend Per Share (TTM) | $8.52 | |||
| Payout Ratio (TTM) | 58.90% | |||
| Dividend Per Share (Most Recent) | $2.13 | |||
| Company Info | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 805 447 1000 | |||
| Address | One Amgen Center Drive Thousand Oaks, CA 91320-1799 | |||
| Website | www.amgen.com | |||
| Country | United States | |||
| Year Founded | 1980 | |||
| Profitability | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 36.08% | |||
| Profit Margin | 28.19% | |||
| Management Effectiveness | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 7.85% | |||
| Return on Equity | 133.80% | |||
| Income Statement | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | $25.63B | |||
| Total Revenue (TTM) | $26.83B | |||
| Revenue Per Share | $49.88 | |||
| Gross Profit (TTM) | $19.75B | |||
| EBITDA (TTM) | $13.29B | |||
| EBIT (TTM) | $9.68B | |||
| Net Income (TTM) | $7.57B | |||
| Net Income Avl. to Common (TTM) | $7.57B | |||
| Total Revenue Growth (Q YOY) | 3.77% | |||
| Earnings Growth (Q YOY) | -19.27% | |||
| EPS Diluted (TTM) | $14.06 | |||
| EPS Diluted Growth (Q YOY) | -19.10% | |||
| Balance Sheet | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | $34.74B | |||
| Cash Per Share (Q) | $64.57 | |||
| Total Current Assets (Q) | $48.48B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | $7.66B | |||
| Current Ratio (Q) | 2.859 | |||
| Book Value Per Share (Q) | $14.31 | |||
| Total Assets (Q) | $90.53B | |||
| Total Current Liabilities (Q) | $16.95B | |||
| Total Debt (Q) | $60.47B | |||
| Total Liabilities (Q) | $82.88B | |||
| Total Common Equity (Q) | $7.66B | |||
| Cash Flow | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -$2.59B | |||
| Cash from Financing (TTM) | $17.25B | |||
| Net Change in Cash (TTM) | $25.24B | |||
| Levered Free Cash Flow (TTM) | $8.90B | |||
| Cash from Operations (TTM) | $10.58B | |||
